The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Angiotensin-(1-7) Dilates Canine Coronary Arteries Through Kinins and Nitric Oxide
Abstract
Abstract Angiotensin-(1-7) [Ang-(1-7)] was recently recognized to have novel biological functions that are distinct from those of Ang II. In these studies, we determined the vasoactive effects of Ang-(1-7) together with the endothelium-dependent mediator(s) of these responses in canine coronary arteries. Isometric tension was measured in intact canine coronary artery rings suspended in organ chambers perfused with 95% O 2/5% CO 2 at 37°C. Ang-(1-7) caused significant concentration-dependent vascular relaxation (2.73±0.58 μmol/L, EC 50) of rings precontracted with the thromboxane A 2 analogue U46,619. Pretreatment with the nitric oxide synthase inhibitor Nω-nitro-l-arginine (1 mol/L) abolished the vasodilator response to Ang-(1-7), whereas treatment with the cyclooxygenase inhibitor indomethacin (10 μmol/L) was without effect. The vasodilator response produced by Ang-(1-7) was blocked by 75% with the bradykinin B 2 receptor antagonist Hoe 140 (1 μmol/L) or by 80% with the nonselective Ang II antagonist [Sar 1,Thr 8]-Ang II (1 μmol/L). In contrast, the selective AT 1 or AT 2 Ang II antagonists CV 11974 (1 μmol/L) and PD 123319 (1 μmol/L), respectively, were ineffective in inhibiting the Ang-(1-7)–elicited vasodilation. Furthermore, pretreatment of the coronary rings with 2 μmol/L Ang-(1-7) markedly potentiated the bradykinin response. These results suggest that Ang-(1-7) elicits coronary vasodilation that is specifically mediated by the endothelium-dependent release of nitric oxide. These responses involve a B 2 bradykinin receptor and a non-AT 1, non-AT 2 angiotensin receptor. These data suggest that increases in circulating levels of Ang-(1-7) accompanying long-term administration of converting enzyme inhibitors or Ang II receptor blockers may contribute to the cardioprotective actions of these drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Renin-angiotensin system: biochemistry and mechanisms of action.
Peach, M. J. (1977) · Physiological Reviews · doi:10.1152/physrev.1977.57.2.313 · Cited by 1,378
Erdös, E. G. (1990) · Hypertension · doi:10.1161/01.hyp.16.4.363 · Cited by 412
Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides.
Campbell, D. J., Kladis, A., & Duncan, A. M. (1994) · Hypertension · doi:10.1161/01.hyp.23.4.439 · Cited by 317
Angiotensin-(1-7) Inhibits Vascular Smooth Muscle Cell Growth
Freeman, E. J., Chisolm, G. M., Ferrario, C. M., & Tallant, E. A. (1996) · Hypertension · doi:10.1161/01.hyp.28.1.104 · Cited by 295
Self-citationSchiavone, M. T., Santos, R. A., Brosnihan, K. B., Khosla, M. C., & Ferrario, C. M. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4095 · Cited by 288
Self-citationCoronary Kinin Generation Mediates Nitric Oxide Release After Angiotensin Receptor Stimulation
Seyedi, N., Xu, X., Nasjletti, A., & Hintze, T. H. (1995) · Hypertension · doi:10.1161/01.hyp.26.1.164 · Cited by 254
Pörsti, I., Bara, A. T., Busse, R., & Hecker, M. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb14787.x · Cited by 239
Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats
Benter, I. F., Ferrario, C. M., Morris, M., & Diz, D. I. (1995) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1995.269.1.h313 · Cited by 225
Self-citationCardiovascular actions of angiotensin(1–7)
Benter, I. F., Diz, D. I., & Ferrario, C. M. (1993) · Peptides · doi:10.1016/0196-9781(93)90097-z · Cited by 201
Self-citationAngiotensin-(1-7): a new hormone of the angiotensin system.
Ferrario, C. M., Brosnihan, K. B., Diz, D. I., Jaiswal, N., Khosla, M. C., Milsted, A., & Tallant, E. A. (1991) · Hypertension · doi:10.1161/01.hyp.18.5_suppl.iii126 · Cited by 182
Self-citationNephrectomy, converting enzyme inhibition, and angiotensin peptides.
Campbell, D. J., Kladis, A., & Duncan, A. M. (1993) · Hypertension · doi:10.1161/01.hyp.22.4.513 · Cited by 180
Angiotensin-(1-7) Potentiates the Hypotensive Effect of Bradykinin in Conscious Rats
Paula, R. D., Lima, C. V., Khosla, M. C., & Santos, R. A. S. (1995) · Hypertension · doi:10.1161/01.hyp.26.6.1154 · Cited by 160
Angiotensin(1–7) in the spontaneously hypertensive rat
Kohara, K., Brosnihan, K. B., & Ferrario, C. M. (1993) · Peptides · doi:10.1016/0196-9781(93)90063-m · Cited by 152
Self-citationBradykinin peptides in kidney, blood, and other tissues of the rat.
Campbell, D. J., Kladis, A., & Duncan, A.-M. (1993) · Hypertension · doi:10.1161/01.hyp.21.2.155 · Cited by 152
Production of angiotensin-(1-7) by human vascular endothelium.
Santos, R. A. S., Brosnihan, K. B., Jacobsen, D. W., DiCorleto, P. E., & Ferrario, C. M. (1992) · Hypertension · doi:10.1161/01.hyp.19.2_suppl.ii56 · Cited by 151
Self-citationDifferential responses to angiotensin-(1–7) in the feline mesenteric and hindquarters vascular beds
Osei, S. Y., Ahima, R. S., Minkes, R. K., Weaver, J. P., Khosla, M. C., & Kadowitz, P. J. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90703-k · Cited by 147
Jaiswal, N., Diz, D. I., Chappell, M. C., et al. (1992) · Hypertension · doi:10.1161/01.hyp.19.2_suppl.ii49 · Cited by 132
Angiotensin-(1-7) and Nitric Oxide Interaction in Renovascular Hypertension
Nakamoto, H., Ferrario, C. M., Fuller, S. B., Robaczewski, D. L., Winicov, E., & Dean, R. H. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.796 · Cited by 109
Self-citationModulation of phospholipase A2 activity and sodium transport by angiotensin-(1-7)
Leyen, S. A., Romero, M. F., Khosla, M. C., et al. (1993) · Kidney International · doi:10.1038/ki.1993.334 · Cited by 101
Moriguchi, A., Tallant, E. A., Matsumura, K., Reilly, T. M., Walton, H. L., Ganten, D., & Ferrario, C. M. (1995) · Hypertension · doi:10.1161/01.hyp.25.6.1260 · Cited by 90
Self-citationComparative effects of angiotensin-(1-7) and angiotensin II on piglet pial arterioles.
Meng, W., & Busija, D. W. (1993) · Stroke · doi:10.1161/01.str.24.12.2041 · Cited by 89
Schrör, K. (1992) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199200209-00013 · Cited by 75
The renin-angiotensin system during acute myocardial ischemia in dogs.
Santos, R. A. S., Brum, J. M., Brosnihan, K. B., & Ferrario, C. M. (1990) · Hypertension · doi:10.1161/01.hyp.15.2_suppl.i121 · Cited by 62
Self-citationCharacterization of angiotensin receptors mediating prostaglandin synthesis in C6 glioma cells
Jaiswal, N., Diz, D. I., Tallant, E. A., Khosla, M. C., & Ferrario, C. M. (1991) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1991.260.5.r1000 · Cited by 62
Self-citationRole of Endothelium-Derived Bradykinin in the Control of Vascular Tone
Hecker, M., Dambacher, T., & Busse, R. (1992) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199200209-00011 · Cited by 40
A new myocardial conversion of angiotensin I
Ferrario, C. M., & Chappell, M. C. (1994) · Current Opinion in Cardiology · doi:10.1097/00001573-199409000-00004 · Cited by 20
Self-citationConverting-enzyme inhibitors potentiate bradykinin-induced relaxation in vitro
Félétou, M., Germain, M., & Teisseire, B. (1992) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1992.262.3.h839 · Cited by 16
Cited by
Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas
Santos, R. A. S., e Silva, A. C. S., Maric, C., Silva, D. M. R., Machado, R. P., de Buhr, I., Heringer-Walther, S., Pinheiro, S. V. B., Lopes, M. T., Bader, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432869100 · Cited by 1,801
The ACE2/angiotensin-(1-7)/MAS Axis of the renin-angiotensin system: focus on angiotensin-(1-7)
Santos, R. A. S., Sampaio, W. O., Alzamora, A. C., Motta-Santos, D., Alenina, N., Bader, M., & Campagnole-Santos, M. J. (2018) · Physiological Reviews · doi:10.1152/physrev.00023.2016 · Cited by 1,144
Obesity, Adipose Tissue and Vascular Dysfunction
Koenen, M., Hill, M. A., Cohen, P., & Sowers, J. R. (2021) · Circulation Research · doi:10.1161/circresaha.121.318093 · Cited by 904
Liu, Y. H., Yang, X. P., Sharov, V. G., Nass, O., Sabbah, H. N., Peterson, E., & Carretero, O. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119360 · Cited by 603
Carey, R. M., & Siragy, H. M. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0001 · Cited by 603
Metadata
- Authors
- Brosnihan, K. B., Li, P., & Ferrario, C. M.
- Venue
- Hypertension
- Published
- 1996-03
- Volume
- 27
- Issue
- 3
- Pages
- 523-528
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2080248232
- Cited by
- 404
- References
- 27
- FWCI
- 16.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.